Yatharth Hospital Tra Ca Ser Share Price
Sector:
513.60 +7.40 (1.46%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
503.60
Today’s High
515.80
52 Week Low
345.35
52 Week High
692.85
514.10 +8.60 (1.70%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
503.95
Today’s High
516.70
52 Week Low
345.60
52 Week High
693.00
Key Metrics
- Market Cap (In Cr) 4872.24
- Beta -
- Div. Yield (%) 0
- P/B 3.09
- TTM P/E 28.15
- Sector P/E 22.67
- D/E 0
- Open Price 506.05
- Prev Close 506.2
Yatharth Hospital Tra Ca Ser Analysis
Price Analysis
-
1 Week-1.29%
-
3 Months19.23%
-
6 Month-18.12%
-
YTD-9.27%
-
1 Year22.65%
Risk Meter
- 42% Low risk
- 42% Moderate risk
- 42% Balanced Risk
- 42% High risk
- 42% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 1
- 1
- 1
- 1
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Yatharth Hospital Tra Ca Ser News
Q4 results today: GIC, Aurobindo Pharma, Sumitomo Chemical, Nazara Tech, more
1 min read . 26 May 2025THIS smallcap hospital stock up 90% since IPO; another 44% upside seen
3 min read . 30 Sep 2024Up 36% from IPO price, SMIFS sees another 60% upside in this hospital stock
3 min read . 28 May 2024Yatharth Hospitals: 6 key reasons why SMIFS sees 36% upside in the stock
5 min read . 28 Feb 2024Yatharth Hospital Tra Ca Ser Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 880.49
- Selling/ General/ Admin Expenses Total
- 162.5
- Depreciation/ Amortization
- 57.17
- Total Operating Expense
- 398.2
- Operating Income
- 482.29
- Net Income Before Taxes
- 171.74
- Net Income
- 130.55
- Diluted Normalized EPS
- 14.72
- Period
- 2025
- Total Assets
- 1731.18
- Total Liabilities
- 125.72
- Total Equity
- 1605.46
- Tangible Book Valueper Share Common Eq
- 155.75
- Period
- 2025
- Cashfrom Operating Activities
- 149.62
- Cashfrom Investing Activities
- -420.16
- Cashfrom Financing Activities
- 519.5
- Net Changein Cash
- 248.95
- Period
- 2024
- Total Revenue
- 670.55
- Selling/ General/ Admin Expenses Total
- 278.47
- Depreciation/ Amortization
- 29.3
- Other Operating Expenses Total
- 43.39
- Total Operating Expense
- 499.11
- Operating Income
- 171.44
- Net Income Before Taxes
- 156.83
- Net Income
- 114.48
- Diluted Normalized EPS
- 14.44
- Period
- 2024
- Total Assets
- 1019.33
- Total Liabilities
- 145.01
- Total Equity
- 874.32
- Tangible Book Valueper Share Common Eq
- 94.89
- Period
- 2024
- Cashfrom Operating Activities
- -3.08
- Cashfrom Investing Activities
- -225.87
- Cashfrom Financing Activities
- 304.21
- Net Changein Cash
- 75.26
- Period
- 2023
- Total Revenue
- 520.29
- Selling/ General/ Admin Expenses Total
- 219.52
- Depreciation/ Amortization
- 27.51
- Other Operating Expenses Total
- 47.44
- Total Operating Expense
- 401.11
- Operating Income
- 119.18
- Net Income Before Taxes
- 87.68
- Net Income
- 65.77
- Diluted Normalized EPS
- 7.66
- Period
- 2023
- Total Assets
- 485.97
- Total Liabilities
- 303
- Total Equity
- 182.96
- Tangible Book Valueper Share Common Eq
- 16.69
- Period
- 2023
- Cashfrom Operating Activities
- 63.78
- Cashfrom Investing Activities
- -20.31
- Cashfrom Financing Activities
- -17.75
- Net Changein Cash
- 25.73
- Period
- 2022
- Total Revenue
- 400.94
- Selling/ General/ Admin Expenses Total
- 155.74
- Depreciation/ Amortization
- 27.87
- Other Operating Expenses Total
- 29.7
- Total Operating Expense
- 306.82
- Operating Income
- 94.11
- Net Income Before Taxes
- 63.11
- Net Income
- 44.16
- Diluted Normalized EPS
- 5.14
- Period
- 2022
- Total Assets
- 426.02
- Total Liabilities
- 309.14
- Total Equity
- 116.88
- Tangible Book Valueper Share Common Eq
- 8.99
- Period
- 2022
- Cashfrom Operating Activities
- 60.01
- Cashfrom Investing Activities
- -52.18
- Cashfrom Financing Activities
- -1.12
- Net Changein Cash
- 6.71
- Period
- 2021
- Total Revenue
- 228.67
- Selling/ General/ Admin Expenses Total
- 84.82
- Depreciation/ Amortization
- 20.56
- Other Operating Expenses Total
- 16.97
- Total Operating Expense
- 178
- Operating Income
- 50.68
- Net Income Before Taxes
- 28.12
- Net Income
- 18.16
- Diluted Normalized EPS
- 2.12
- Period
- 2021
- Total Assets
- 308.77
- Total Liabilities
- 236.32
- Total Equity
- 72.46
- Tangible Book Valueper Share Common Eq
- 8.39
- Period
- 2021
- Cashfrom Operating Activities
- 43.67
- Cashfrom Investing Activities
- -21.24
- Cashfrom Financing Activities
- -19.05
- Net Changein Cash
- 3.39
- Period
- 2020
- Total Revenue
- 146.04
- Selling/ General/ Admin Expenses Total
- 59.39
- Depreciation/ Amortization
- 21.29
- Other Operating Expenses Total
- 12.06
- Total Operating Expense
- 126.44
- Operating Income
- 19.6
- Net Income Before Taxes
- -2.49
- Net Income
- -1.3
- Diluted Normalized EPS
- -0.15
- Period
- 2020
- Total Assets
- 287.2
- Total Liabilities
- 232.91
- Total Equity
- 54.29
- Tangible Book Valueper Share Common Eq
- 6.29
- Period
- 2020
- Cashfrom Operating Activities
- 39.23
- Cashfrom Investing Activities
- -43.28
- Cashfrom Financing Activities
- 5.31
- Net Changein Cash
- 1.26
- Period
- 2019
- Total Revenue
- 101.83
- Selling/ General/ Admin Expenses Total
- 44.09
- Depreciation/ Amortization
- 8.38
- Other Operating Expenses Total
- 11.11
- Total Operating Expense
- 87.72
- Operating Income
- 14.11
- Net Income Before Taxes
- 5.02
- Net Income
- 3.98
- Diluted Normalized EPS
- 0.46
- Period
- 2019
- Total Assets
- 256.56
- Total Liabilities
- 200.96
- Total Equity
- 55.6
- Tangible Book Valueper Share Common Eq
- 6.45
- Period
- 2019
- Cashfrom Operating Activities
- 17.46
- Cashfrom Investing Activities
- -77.82
- Cashfrom Financing Activities
- 47.38
- Net Changein Cash
- -12.98
- Period
- 2025-03-31
- Total Revenue
- 231.78
- Selling/ General/ Admin Expenses Total
- 43.82
- Depreciation/ Amortization
- 12.87
- Total Operating Expense
- 103.19
- Operating Income
- 128.59
- Net Income Before Taxes
- 48.53
- Net Income
- 38.72
- Diluted Normalized EPS
- 4.37
- Period
- 2025-03-31
- Total Assets
- 1731.18
- Total Liabilities
- 125.72
- Total Equity
- 1605.46
- Tangible Book Valueper Share Common Eq
- 155.75
- Period
- 2025-03-31
- Cashfrom Operating Activities
- 149.62
- Cashfrom Investing Activities
- -420.16
- Cashfrom Financing Activities
- 519.5
- Net Changein Cash
- 248.95
- Period
- 2024-12-31
- Total Revenue
- 219.16
- Selling/ General/ Admin Expenses Total
- 42.61
- Depreciation/ Amortization
- 16.91
- Total Operating Expense
- 101.59
- Operating Income
- 117.56
- Net Income Before Taxes
- 40.16
- Net Income
- 30.49
- Diluted Normalized EPS
- 3.57
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 217.77
- Selling/ General/ Admin Expenses Total
- 41.46
- Depreciation/ Amortization
- 15.95
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 100.57
- Operating Income
- 117.2
- Net Income Before Taxes
- 40.09
- Net Income
- 30.95
- Diluted Normalized EPS
- 3.61
- Period
- 2024-09-30
- Total Assets
- 1093.25
- Total Liabilities
- 160.98
- Total Equity
- 932.27
- Tangible Book Valueper Share Common Eq
- 101.64
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 99.09
- Cashfrom Investing Activities
- -53.43
- Cashfrom Financing Activities
- -2.29
- Net Changein Cash
- 43.37
- Period
- 2024-06-30
- Total Revenue
- 211.78
- Selling/ General/ Admin Expenses Total
- 34.61
- Depreciation/ Amortization
- 11.44
- Total Operating Expense
- 92.85
- Operating Income
- 118.93
- Net Income Before Taxes
- 42.96
- Net Income
- 30.38
- Diluted Normalized EPS
- 3.54
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 177.97
- Selling/ General/ Admin Expenses Total
- 31.87
- Depreciation/ Amortization
- 7.7
- Total Operating Expense
- 77.25
- Operating Income
- 100.71
- Net Income Before Taxes
- 44.11
- Net Income
- 38.35
- Diluted Normalized EPS
- 4.46
- Period
- 2024-03-31
- Total Assets
- 1019.33
- Total Liabilities
- 145.01
- Total Equity
- 874.32
- Tangible Book Valueper Share Common Eq
- 94.89
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -3.08
- Cashfrom Investing Activities
- -225.87
- Cashfrom Financing Activities
- 304.21
- Net Changein Cash
- 75.26
- Period
- 2023-12-31
- Total Revenue
- 166.79
- Selling/ General/ Admin Expenses Total
- 29.93
- Depreciation/ Amortization
- 7.85
- Total Operating Expense
- 69.3
- Operating Income
- 97.49
- Net Income Before Taxes
- 43.78
- Net Income
- 29.49
- Diluted Normalized EPS
- 3.83
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Yatharth Hospital Tra Ca Ser Technical
Moving Average
SMA
- 5 Day518.32
- 10 Day522.65
- 20 Day519.02
- 50 Day500.68
- 100 Day453.7
- 300 Day518.36
Yatharth Hospital Tra Ca Ser Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Krn Heat Exchanger Refrigeration
- 816.25
- 7.1
- 0.88
- 1011.6
- 402.4
- 5073.53
- Bondada Engineering
- 447.7
- 1.15
- 0.26
- 753.98
- 330
- 4925.93
- Yatharth Hospital Tra Ca Ser
- 513.6
- 7.4
- 1.46
- 692.85
- 345.35
- 4872.24
- Entero Healthcare Solutions
- 1118.35
- -21.2
- -1.86
- 1583
- 1015
- 4876.95
- Indus Infra Trust Unt
- 109.66
- -0.02
- -0.02
- 118.51
- 95.21
- 4857.26
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Krn Heat Exchanger Refrigeration
- 83.78
- 10.18
- -
- -
- Bondada Engineering
- 43.55
- 11.01
- -
- -
- Yatharth Hospital Tra Ca Ser
- 34.93
- 3.09
- 17.97
- 13.87
- Entero Healthcare Solutions
- 51.41
- 2.82
- 1.77
- 0.55
- Indus Infra Trust Unt
- 67.48
- 0.98
- -
- -
Yatharth Hospital Tra Ca Ser Shareholding
Shareholding Pattern
*Promoter pledging: 8.51%
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 26-May-25
- Audited Results
- 27-Jan-25
- Quarterly Results
- 07-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 23-May-24
- Audited Results
- 10-Feb-24
- Quarterly Results
- 07-Nov-23
- Quarterly Results
- 17-Aug-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 06-Dec-24
- 14-Nov-24
- EGM
- 28-Sept-24
- 05-Sept-24
- AGM
- 28-Sept-23
- 07-Sept-23
- AGM



